New combo fights debilitating cancer fatigue
NCT ID NCT03525873
Summary
This study aims to see if a common stimulant medication (methylphenidate) combined with a guided exercise program can reduce severe, cancer-related fatigue. It involves 212 patients with advanced cancer who are receiving a specific type of immunotherapy (anti-PD1) and are struggling with significant tiredness. Participants are randomly assigned to receive either the real medication or a placebo, while everyone follows the same physical activity plan, to compare the effects on their energy levels and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.